RecruitingNot ApplicableNCT07639333

GRACE - Genetic Insights Into Early pRegnancy Loss Using Cell-free fEtal DNA

GRACE - Genetic Insights Into Early pRegnancy Loss: A Prospective Study Using Cell-free fEtal DNA


Sponsor

Rennes University Hospital

Enrollment

100 participants

Start Date

Sep 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to assess the impact of non-invasive prenatal testing right after an early isolated miscarriage on mental health and on the patient's subsequent care in the year following the miscarriage


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 43 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Non invasive prenatal test for people with miscarriage in first trimester and prenatal genetic diagnosis. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 43 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICNon invasive prenatal test

cell free fetal DNA analysis


Locations(1)

CHU Rennes

Rennes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07639333


Related Trials